ArticleScientific reports2021
Epidemiological and economic impact of COVID-19 in the US.
Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 73 citations in OpenAlex.
- Time-managed PAPR use enables a balanced approach to infection control and personal freedom.Scientific reports · 2025Article
- Economic Analyses of COVID-19 Interventions: A Narrative Review of Global Evidence.Healthcare (Basel, Switzerland) · 2025Review
- Psychological distress and compliance with sanitary measures during the Covid-19 pandemic.PloS one · 2025Article
- Existence and stability of equilibria in infectious disease dynamics with behavioral feedback.Physical review. E · 2025Article
- A novel comparison framework for epidemiological strategies applied to age-based restrictions versus horizontal lockdowns.Infectious Disease Modelling · 2024Article
- The macroeconomic impact of a dengue outbreak: Case studies from Thailand and Brazil.PLoS neglected tropical diseases · 2024Article
- Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study.PharmacoEconomics · 2024Article
- Assessing the Impact of Non-Pharmaceutical Interventions on Consumer Mobility Patterns and COVID-19 Transmission in the US.International journal of environmental research and public health · 2024Article
- Number and nature of psychiatric emergency department visits in a tertiary hospital before, during, and after coronavirus pandemic.Frontiers in psychiatry · 2024Article
- The optimisation of public health emergency governance: a simulation study based on COVID-19 pandemic control policy.Globalization and health · 2023Article
- Evaluation of vaccine rollout strategies for emerging infectious diseases: A model-based approach including protection attitudes.Infectious Disease Modelling · 2023Article
- The Epidemiological and Economic Impact of COVID-19 in Kazakhstan: An Agent-Based Modeling.Healthcare (Basel, Switzerland) · 2023Article
- Household hardships and responses to COVID-19 pandemic-related shocks in Eastern Ethiopia.BMC public health · 2023Article
- Stabilizing the return to normal behavior in an epidemic.medRxiv : the preprint server for health sciences · 2023Article
- Examining standardized consumer-generated social determinants of health and resilience data supported by Omaha System terminology.Journal of the American Medical Informatics Association : JAMIA · 2023Article
- Epidemic Management via Imperfect Testing: A Multi-criterial Perspective.Bulletin of mathematical biology · 2023Article
- Simplified within-host and Dose-response Models of SARS-CoV-2.Journal of theoretical biology · 2023Article
- Modeling social, economic, and health perspectives for optimal pandemic policy decision-making.Socio-economic planning sciences · 2023Article
- The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study.Vaccines · 2023Article
- Substance use in rural trauma patients admitted for motor vehicle injuries before and during the COVID-19 pandemic.Injury epidemiology · 2023Article
Corrections and comments
- Update of
Authors and funding
12 authors at 4 institutions in 1 country.
Funding
Abstract
This research measures the epidemiological and economic impact of COVID-19 spread in the US under different mitigation scenarios, comprising of non-pharmaceutical interventions. A detailed disease model of COVID-19 is combined with a model of the US economy to estimate the direct impact of labor supply shock to each sector arising from morbidity, mortality, and lockdown, as well as the indirect impact caused by the interdependencies between sectors. During a lockdown, estimates of jobs that are workable from home in each sector are used to modify the shock to labor supply. Results show trade-offs between economic losses, and lives saved and infections averted are non-linear in compliance to social distancing and the duration of the lockdown. Sectors that are worst hit are not the labor-intensive sectors such as the Agriculture sector and the Construction sector, but the ones with high valued jobs such as the Professional Services, even after the teleworkability of jobs is accounted for. Additionally, the findings show that a low compliance to interventions can be overcome by a longer shutdown period and vice versa to arrive at similar epidemiological impact but their net effect on economic loss depends on the interplay between the marginal gains from averting infections and deaths, versus the marginal loss from having healthy workers stay at home during the shutdown.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.